Profile
APEN ABT BSX-PA BSX SYK MDT
Company Name Apollo Endosurgery, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $579.72M $196.03B $175.45B $140.97B $138.31B $109.32B
Employees 0.20K 114.00K 45.00K 48.00K 52.00K 95.00K
CEO Mr. Charles S. McKhann Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
APEN ABT BSX-PA BSX SYK MDT
Quant Rating Score 3 3 2 3 3
Quant Rating Neutral Neutral Sell Neutral Neutral
Trading
APEN ABT BSX-PA BSX SYK MDT
Last Close $10 $113.02 $122.18 $95.65 $362.8 $85.25
High 52 $10 $120.98 $122.18 $95.95 $392.15 $92.27
Low 52 $10 $100.07 $122.18 $59.92 $307.75 $76.84
Price vs. 52 Week High 0 % -6.58 % 0 % -0.31 % -7.48 % -7.61 %
Price vs. 52 Week Low 0 % 12.94 % 0 % 59.63 % 17.89 % 10.94 %
Total Return
APEN ABT BSX-PA BSX SYK MDT
1 Month Return 0 % -0.32 % 0 % 6.15 % -3.15 % 3.36 %
3 Month Return 0 % -2.61 % 0 % 10.23 % 1.06 % -5.11 %
6 Month Return 0 % 9.77 % 0 % 22.6 % 10.42 % 10.6 %
9 Month Return 0 % 3.79 % 0 % 41.83 % 6.98 % 6.26 %
YTD Return 0 % -0.08 % 0 % 7.09 % 0.76 % 6.72 %
1 Year Return 0 % -0.79 % 0 % 59.58 % 15.95 % -2.48 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APEN ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.46 % - - 0.89 % 3.27 %
Dividend Paid and Capex Coverage Ration (TTM) -11.39 % 1.45 % 2.95 % 2.95 % 2.09 % 1.35 %
Dividend Per Share (TTM) - 1.65 % - - 3.24 % 2.79 %
Payout Ratio (TTM) - 65.3 % 1.29 % 1.29 % 33.4 % 84.54 %
Growth
APEN ABT BSX-PA BSX SYK MDT
Asset Growth -16.19 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth 21.36 % -9.7 % 14.01 % 14.01 % 13.12 % 3.12 %
Revenue Growth 22.01 % -8.12 % 12.29 % 12.29 % 11.11 % 3.64 %
Revenue 3 Year -19.69 % 18.5 % 40.06 % 40.06 % 41.29 % 8.85 %
Revenue 5 Year -60.12 % 32.8 % 37.78 % 37.78 % 48.53 % 7.41 %
Revenue 10 Year -96.06 % 63.89 % 84.02 % 84.02 % 126.63 % 43.65 %
EBIT Growth -44.91 % -22.53 % 42.09 % 42.09 % 36.85 % -6.22 %
Net Income Growth -61.41 % -17.45 % 128.22 % 128.22 % 34.22 % -2.18 %
Net Income 3 Yeari Growth Per Share 23.04 % 30.18 % 1209.43 % 1209.43 % 95.8 % 3.26 %
Net Income 5 Yeari Growth Per Share 51.29 % 144.68 % -9.39 % -9.39 % -12.21 % -19.5 %
Net Income 10 Yeari Growth Per Share 95.03 % 98.34 % 1315.23 % 1315.23 % 213.78 % -9.48 %
Operating Income Growth -44.91 % -22.53 % 42.09 % 42.09 % 36.85 % -6.22 %
Operating Cash Flow Growth (CFG) -116.29 % -24.21 % 64.02 % 64.02 % 41.43 % 12.39 %
Operating 3 Year CFG 35.34 % -6.04 % 61.83 % 61.83 % 12.02 % 10.18 %
Operating 5 Year CFG 21.68 % 16.69 % 667.41 % 667.41 % 40.12 % -1.78 %
Operating 10 Year CFG 98.71 % 95.01 % 113.53 % 113.53 % 96.25 % 3.3 %
EPS Growth -19.51 % -16.24 % 140 % 140 % 33.87 % -2.12 %
EPS Diluted Growth -19.51 % -16.37 % 137.78 % 137.78 % 33.71 % -2.13 %
Book Value Per Share -60.4 % 6.36 % 9.41 % 9.41 % 11.49 % -2.26 %
Share Holder 3 Year Equity Growth Per Share 713.61 % 20.39 % 22.66 % 22.66 % 40.57 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -78.21 % 28.04 % 110.05 % 110.05 % 56.21 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -99.25 % 36.91 % 172.19 % 172.19 % 104.97 % 94.93 %
Dividend Per Share Growth - 8.64 % -49.88 % -49.88 % 7.97 % 1.54 %
Dividend 3 Year Growth Per Share - 42.02 % -2.5 % -2.5 % 30.56 % 19.02 %
Dividend 5 Year Growth Per Share - 82.38 % - - 59.67 % 38.05 %
Dividend 10 Year Growth Per Share - 259.93 % - - 183.29 % 147.94 %
Debt Growth 6.52 % -10.4 % 2.26 % 2.26 % -0.41 % 6.91 %
Free Cash Flow Growth -113.75 % -35.17 % 86.32 % 86.32 % 54.03 % 13.54 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
APEN ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 55.2 % 54.7 % 67.3 % 67.3 % 62.47 % 62.65 %
Return on Assets TTM -36.14 % 7.76 % 4.7 % 4.7 % 8.19 % 4.76 %
Return on Equity TTM -84.92 % 14.74 % 8.91 % 8.91 % 18.49 % 8.64 %
Return on Capital Employed TTM -39.35 % 11.6 % 8.57 % 8.57 % 12.38 % 7.56 %
Net Income Per EBT TTM 101.49 % 85.08 % 81.24 % 81.24 % 85.68 % 83.18 %
EBT Per Ebit TTM 141.09 % 98.29 % 79.87 % 79.87 % 93.61 % 87.63 %
EBIT Per Revenue TTM -36.2 % 16.73 % 17.33 % 17.33 % 20.37 % 17.83 %
Cash Flow To Debt Ratio TTM -57.66 % 58.27 % 26.08 % 26.08 % 24.79 % 25.4 %
Receivables Turnover TTM 5.13 4.48 6.36 6.36 5.88 5.27
Payables Turnover TTM 4.64 4.63 5.74 5.74 6.17 5.19
Inventory Turnover TTM 1.89 2.74 1.89 1.89 1.56 2.25
Fixed Asset Turnover TTM 1023.79 % 388.07 % 454.83 % 454.83 % 557.01 % 512.52 %
Asset Turnover TTM 69.72 % 55.43 % 41.78 % 41.78 % 50.13 % 36.65 %
Operating Cash Flow Per Share TTM -0.77 5.03 1.99 1.99 10.07 5.61
Free Cash Flow Per Share TTM -0.84 3.74 1.33 1.33 8.41 4.29
Cash Per Share TTM 140.23 % 449.02 % 169.89 % 169.89 % 1229.07 % 622.97 %
Operating Cash Flow Sales Ratio TTM -40.68 % 21.18 % 18.45 % 18.45 % 17.47 % 21.81 %
Free Cash Flow Operating Cash Flow Ratio TTM 108.78 % 74.31 % 66.93 % 66.93 % 83.49 % 76.43 %
Cash Flow Coverage Ratios TTM -57.66 % 58.27 % 26.08 % 26.08 % 24.79 % 25.4 %
Price To Free Cash Flows Ratio TTM -17.05 30.22 72.71 71.74 43.15 19.88
Price To Operating Cash Flows Ratio TTM -13 22.46 48.63 47.98 36.02 15.19
Price Cash Flow Ratio TTM -13 22.46 48.63 47.98 36.02 15.19
Income Statement (TTM)
APEN ABT BSX-PA BSX SYK MDT
Revenue $0.08B $40.11B $14.24B $14.24B $20.5B $32.36B
Gross Profit $0.04B $22.13B $9.9B $9.9B $13.1B $21.15B
Gross Profit Ratio 55.2% 55.18% 69.49% 69.49% 63.89% 65.34%
EBITDA $-0.03B $10.61B $3.45B $3.45B $4.93B $8.2B
Net Income $-0.04B $5.72B $1.59B $1.59B $3.17B $3.68B
EPS Diluted -0.98 3.27 1.07 1.07 8.25 2.76
Balance Sheet (MRQ)
APEN ABT BSX-PA BSX SYK MDT
Long Term Debt $0.03B $14.55B $8.96B $8.96B $11.26B $24.77B
Total Liabilities $0.08B $34.39B $15.61B $15.61B $21.32B $39.56B
Total Equity $0.03B $38.83B $19.53B $19.53B $18.59B $50.42B
Total Investments $0B $1.18B $0.41B $0.41B $0.08B $8.34B
Total Debt $0.06B $15.87B $9.49B $9.49B $13B $26.05B
Total Assets $0.11B $73.21B $35.14B $35.14B $39.91B $89.98B
Cash Flow Statement (TTM)
APEN ABT BSX-PA BSX SYK MDT
Net Income $-0.04B $5.72B $1.59B $1.59B $3.17B $3.68B
Inventory $-0.01B $-0.23B $-0.66B $-0.66B $-0.8B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-0.03B $-1.14B $-3.67B
Operating Cash Flow $-0.03B $7.26B $2.5B $2.5B $3.71B $6.79B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.8B $-0.58B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 111
AEMD Aethlon Medical, Inc. 0.6391
AFIB Acutus Medical, Inc. 0.07
AHCO AdaptHealth Corp. 10.38
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 214.98
ALUR Allurion Technologies Inc. 3.21
AMIX Autonomix Medical, Inc. Common Stock 2.62
ANIK Anika Therapeutics, Inc. 15.86
AORT Artivion, Inc. 29.91
APYX Apyx Medical Corporation 1.5
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.27
AVNS Avanos Medical, Inc. 15.82
AXDX Accelerate Diagnostics, Inc. 1.08
AXGN AxoGen, Inc. 18.54
AXNX Axonics, Inc. 70.98
AZYO Aziyo Biologics, Inc. 1.49
BBLG Bone Biologics Corporation 0.98
ETFs With Exposure to APEN
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 129.79
IWC iShares Micro-Cap ETF 0.05 127.585
DFAS Dimensional U.S. Small Cap ETF 0 66.2606
QQQS Invesco NASDAQ Future Gen 200 ETF 0.53 28.99
Unlock